PMS30 - COST ANALYSIS FOR DIFFERENT ANTI-RHEUMATOID BIOLOGICAL TREATMENTS AFTER FAILURE OF CONVENTIONAL DMARDS IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN THE KINGDOM OF SAUDI ARABIA
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1744
https://www.valueinhealthjournal.com/article/S1098-3015(18)35046-0/fulltext
Title :
PMS30 - COST ANALYSIS FOR DIFFERENT ANTI-RHEUMATOID BIOLOGICAL TREATMENTS AFTER FAILURE OF CONVENTIONAL DMARDS IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN THE KINGDOM OF SAUDI ARABIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35046-0&doi=10.1016/j.jval.2018.09.1744
First page :
Section Title :
Open access? :
No
Section Order :
1105